FDA warns Allergan Website too Skimpy on Latisse Warnings

The makers of Latisse can’t bat their lashes out of this one.

Latisse mascara, developed by Allergan Inc. from glaucoma medication, triggers eyelashes to grow at a quick rate and is approved for “thicker, fuller and darker” lashes. The Food and Drug Administration, however, has given the company a warning for their website and promo materials for failing to promote the side effects of the products as well as the intended benefits.

In my post from January on Latisse’s release I mentioned a few of the issues the medication could cause,  and here is another rundown:

• Permanent darkening of blues eyes to brown
• Irritation
• Bacterial eye infection
• Excess hair growth outside treatment area

It was found that Latisse warnings were sometimes missing on the website while present on other materials.  The FDA has asked Allergan to stop using all current promotional materials that omit the information of these potentially serious side effects and to respond to the agency by September 24th.

If you weren’t aware of these issues before, does an awareness stop you from using or potentially using the product?